Latest news & insights
Nanomedicine comes of age
European researchers take nanotech-based therapies (nanomedicine) from the lab to the clinic With more than 50 nanomedicine formulations already in the market and over 400
Victoria Marsh joins the team as Director of Regulatory Affairs
Responding to sustained growth in demand for our Regulatory Services, Boyds has appointed Dr Victoria Marsh, a specialist in molecular biology and protein biochemistry, as
Boyds assists researchers and developers on COVID-19 projects
Boyds has a wealth of experience in early development and translational medicine and we are already supporting a number of vital COVID-19 projects. As this
Dr Kim Champion joins the team as Regulatory Affairs Manager
We are delighted to welcome Dr Kim Champion to the Boyds team as Regulatory Affairs Manager. With extensive experience in the Clinical Operations sphere, Kim
Professor Alan Boyd tells his story on The Cat 107.9FM
Following Boyds’ success in the South Cheshire Chamber of Commerce Awards, when the company won Business of the Year (under 25 employees), Professor Alan Boyd
Horizon 2020 New Deal project for treatment of inflammatory bowel diseases
Boyds has been working with New Deal and a team of European partners on a nanotherapy research project into the treatment of inflammatory bowel diseases.
Evolution of Ethical Principles in the Practice of Pharmaceutical Medicine From a UK Perspective
Professor Alan Boyd has co-authored a paper which looks at ethical principles in the practice of pharmaceutical medicine, published this month in Frontiers in Pharmacology.
Boyds scoop Business of the Year at South Cheshire Chamber Awards
Boyds took away the award for Business of the Year (under 25 employees) at the 2019 South Cheshire Chamber of Commerce Business Awards. The annual
